Congrats to WellTheory on their $14M Series A raise. Their work is reshaping care delivery for autoimmune disease—one of the most urgent health challenges of our time.
📢 Big news from WellTheory: We’ve raised $14M in Series A funding led by General Catalyst. Autoimmune disease affects 50M+ Americans and is one of the fastest-growing and most expensive areas in healthcare. Yet many autoimmune patients are left to navigate fragmented, one-size-fits-all care that aims to mask instead of heal. That’s why we’re building something different: personalized, whole-person, root-cause care that’s powered by AI and delivered with compassion. With this raise, we’ll expand access to our revolutionary care model, deepen our work with employers and payors, and continue building what we’ve always believed possible: a better way to care for autoimmune disease. To our team and investors: thank you for believing in this vision. To our members: thank you for entrusting us with your health and for reminding us why this work matters every day. Read more here: welltheory.com/seriesa P.S. We’re growing fast and hiring across teams. If you feel called to our mission and driven by grit, resilience, and a belief that change happens when people refuse to accept the status quo — we’d love to meet you: https://lnkd.in/gM2Xwewg